Science · Open for opinions
Will Life Biosciences release preliminary data from the ER-100 clinical trial by November 30, 2026?
Considers announcements regarding the first human clinical trial of partial cellular reprogramming between 10/17 and 11/30. 81 opinions, 65% No
- Yes — 35%
- No — 65%
Deadline: November 30, 2026 at 11:59 PM UTC · 81 opinions
Resolution rules
Considers announcements regarding the first human clinical trial of partial cellular reprogramming between 10/17 and 11/30.
Source: www.nature.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 17/10/2026 (00:00, horário de Brasília) até 30/11/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se a Life Biosciences publicar comunicado oficial, artigo científico ou atualização no ClinicalTrials.gov contendo dados preliminares de segurança ou eficácia da Fase 1 da terapia de reprogramação celular ER-100 até 30/11/2026. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 65% of the votes: an opinion on it that turns out right earns about 35 points, a wrong one costs about 65.